Event Details

The Sachs 8th Annual Immuno-Oncology innovation Forum for business development, licensing, and investment will take place on May 24th and 25th.

The program will bring together leaders in the pharmaceutical and biotechnology industries as well as cancer research institutes, patient advocacy groups, and late-stage investors.

Nanobiotix’s CEO, Laurent Levy, and Patrick Tricoli, CEO of Nanobiotix Corp and Global Head of Business Development, will participate to share updates about our work and clinical development strategy for NBTXR3 in the following sessions:

• Fireside chat with Laurent Levy on Tuesday, 24th May, 1:00PM EDT.
• Big Pharma Strategy and M&A Panel including Patrick Tricoli on Tuesday, 24th May, 11:30AM EDT.